Pfizer | Kostnadene For Salg



Cost Of Sales Endring Dato
AbbVie USD 4.4B 184M 2024-12
Abbott USD 4.94B 246M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Bayer EUR 5.72B 633M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 59M 7M 2024-09
J&J USD 7.11B 151M 2024-12
Medtronic USD 2.78B 160M 2025-01
Merck USD 3.71B 181M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 5.65B 781M 2024-12
Prestige Brands USD 129.27M 2.86M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Sanofi EUR 4.08B 675M 2024-09
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zoetis USD 707M 8M 2024-12



Pfizer Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.